CNS Pharmaceuticals, Inc. (CNSP) Financials

CNSP Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 2.3 million 4.1 million
2023-06-30 6.5 million 4.0 million
2023-03-31 7.4 million 3.9 million
2022-12-31 13.1 million 4.9 million

CNSP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.4 million 194759
2023-06-30 -3.4 million 289670
2023-03-31 -4.8 million 290313
2022-12-31 -2.3 million 289719

CNSP Net Income

No data available :(

CNSP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 909547 - -
2023-06-30 4.3 million - -
2023-03-31 5.1 million - -
2022-12-31 10.1 million - -

CNSP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.2 million
2023-06-30 3.9 million
2023-03-31 1.9 million
2022-12-31 1.4 million

CNSP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1744 3.4 million 1.1 million -
2023-06-30 - 2.8 million 1.2 million -
2023-03-31 - 3.6 million 1.4 million -
2022-12-31 1 3.3 million 2.2 million -

CNSP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 899
2023-06-30 - 1003
2023-03-31 - 1279
2022-12-31 - 2381

CNSP

Price: $0.22

52 week price:
0.19
4.40

Earnings Per Share: -10.00 USD

P/E Ratio: -0.04

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 89600

Market Capitalization: 2.6 million

Links: